[HTML][HTML] Small molecules in targeted cancer therapy: advances, challenges, and future perspectives

L Zhong, Y Li, L Xiong, W Wang, M Wu… - Signal transduction and …, 2021 - nature.com
Due to the advantages in efficacy and safety compared with traditional chemotherapy drugs,
targeted therapeutic drugs have become mainstream cancer treatments. Since the first …

[HTML][HTML] Ferroptosis and cancer: mitochondria meet the “iron maiden” cell death

AM Battaglia, R Chirillo, I Aversa, A Sacco, F Costanzo… - Cells, 2020 - mdpi.com
Ferroptosis is a new type of oxidative regulated cell death (RCD) driven by iron-dependent
lipid peroxidation. As major sites of iron utilization and master regulators of oxidative …

Molecular therapies and precision medicine for hepatocellular carcinoma

JM Llovet, R Montal, D Sia, RS Finn - Nature reviews Clinical oncology, 2018 - nature.com
The global burden of hepatocellular carcinoma (HCC) is increasing and might soon surpass
an annual incidence of 1 million cases. Genomic studies have established the landscape of …

Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs

Y Su, B Zhao, L Zhou, Z Zhang, Y Shen, H Lv… - Cancer letters, 2020 - Elsevier
Ferroptosis, a form of regulated cell death, is initiated by oxidative perturbations of the
intracellular microenvironment, which is under the constitutive control of glutathione …

[HTML][HTML] Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma

EJ Sun, M Wankell, P Palamuthusingam, C McFarlane… - Biomedicines, 2021 - mdpi.com
Despite advances in the treatment of cancers through surgical procedures and new
pharmaceuticals, the treatment of hepatocellular carcinoma (HCC) remains challenging as …

[HTML][HTML] The role of cystine/glutamate antiporter SLC7A11/xCT in the pathophysiology of cancer

N Jyotsana, KT Ta, KE DelGiorno - Frontiers in Oncology, 2022 - frontiersin.org
SLC7A11/xCT is an antiporter that mediates the uptake of extracellular cystine in exchange
for glutamate. Cystine is reduced to cysteine, which is a rate-limiting precursor in glutathione …

[HTML][HTML] Angiogenesis in breast cancer progression, diagnosis, and treatment

CO Madu, S Wang, CO Madu, Y Lu - Journal of Cancer, 2020 - ncbi.nlm.nih.gov
Angiogenesis is a significant event in a wide range of healthy and diseased conditions. This
process frequently involves vasodilation and an increase in vascular permeability …

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: the SPACE trial

R Lencioni, JM Llovet, G Han, WY Tak, J Yang… - Journal of …, 2016 - Elsevier
Background & Aims Transarterial chemoembolization with doxorubicin-eluting beads (DC
Bead®; DEB-TACE) is effective in patients with Barcelona clinic liver cancer stage B …

Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis

SJ Dixon, DN Patel, M Welsch, R Skouta, ED Lee… - elife, 2014 - elifesciences.org
Exchange of extracellular cystine for intracellular glutamate by the antiporter system xc− is
implicated in numerous pathologies. Pharmacological agents that inhibit system xc− activity …

Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011)

J Wang, M Sánchez-Roselló, JL Aceña… - Chemical …, 2014 - ACS Publications
1.1. Brief Historical Overview As expected from the fluorine position on the periodic table of
elements, it possesses some extreme properties, in particular, ultimate electronegativity and …